Raleigh Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
LMFP
HGIM
DC
CF
MIHAS
Raleigh Capital Management's ELV Position: Q2 2026 in Review
Raleigh Capital Management reduced its Elevance Health (ELV) stake by 16% in Q2 2026, selling an estimated $14.5K and leaving 199 shares worth $76.9K. The position accounts for 0.02% of the portfolio, ranked #252.
Raleigh Capital Management first reported a position in ELV in Q1 2022 and has held it in 18 quarters since. The position peaked at $293K in Q3 2023. 368 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Raleigh Capital Management held 199 shares of Elevance Health worth $76.9K as of Q2 2026.
- Raleigh Capital Management sold 39 Elevance Health shares in Q2 2026, an estimated $14.5K.
- Elevance Health made up 0.02% of Raleigh Capital Management's portfolio in Q2 2026, its #252 holding.
- Raleigh Capital Management first reported a position in Elevance Health in Q1 2022 and has held it in 18 quarters since.
- Raleigh Capital Management's Elevance Health position peaked at $293K in Q3 2023.
- 368 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.